By Christy Santhosh Oct 22 (Reuters) - AbbVie said on Thursday its experimental drug significantly reduced inflammatory lumps ...

This late-stage readout comes as companies explore the potential of novel mechanisms of action in HS.

AbbVie is eyeing regulatory filings in 2027 for the skin disease drug lutikizumab after clearing multiple endpoints in a late ...

Psoriasis can affect much more than the skin. It may interfere with sleep, contribute to emotional distress and occur ...

Introduction: Skin diseases also affect the mindI'm so itchy that I can't sleep at night.I'm so self-conscious about my acne that I don't want to face people.My child's eczema won't get better, and ...

A targeted antibody that blocks plasmacytoid dendritic cells clears skin in patients with moderate-to-severe cutaneous lupus ...

Fatty liver disease often develops without obvious symptoms, so a person’s appearance is not a reliable way to identify it.

A protein best known for its role in Parkinson’s disease may also help melanoma cells survive. Researchers at Oregon Health & ...

Key TakeawaysMoonLake shares jumped 18% today after AbbVie reported Phase 3 results for a rival hidradenitis suppurativa drug. AbbVie’s lutikizumab beat placebo by 8 percentage points on its main goal ...

Research shows both disease types may arise from shared inflammatory pathways, genetic susceptibilities, and potential ...

Friendly A skin biopsy can identify a protein associated with Parkinson’s, but it cannot name the disease by itself. The ...

Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also ...